Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?

Rev Gastroenterol Mex (Engl Ed). 2023 Oct-Dec;88(4):392-403. doi: 10.1016/j.rgmxen.2023.08.002. Epub 2023 Dec 13.

Abstract

Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.

Keywords: Antivirales de acción directa; Direct-acting antivirals; Donantes de virus de la hepatitis C positivos; Hepatitis C virus; Hepatitis C virus-positive donors; Liver transplant; Trasplante hepático; Virus de la hepatitis C.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepacivirus
  • Hepatitis C* / drug therapy
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / surgery
  • Humans
  • Liver Transplantation*
  • Mexico

Substances

  • Antiviral Agents